Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HRS 9231

Next Previous
X
Search
Drug Profile

HRS 9231

Alternative Names: HRS-9231

Latest Information Update: 18 Dec 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jiangsu Hengrui Medicine Co.
  • Class Contrast media; Imaging agents
  • Mechanism of Action Magnetic resonance imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Vascular disorders

Most Recent Events

  • 12 Dec 2024 Jiangsu HengRui Medicine plans a phase II trial for CNS disorders (Diagnosis) in China (IV) (NCT06731829)
  • 14 Oct 2024 Phase-I clinical trials in Vascular disorders (Diagnosis) in China (IV) (NCT06657560)
  • 29 Jul 2024 Atridia plans a phase-0 trial for Vascular disorders (In volunteers, Diagnosis) in Australia (IV), (NCT06519981)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top